24 related articles for article (PubMed ID: 2271753)
1. Further observations on the disposition characteristics of salicylic acid in analbuminemic rats.
Hirate J; Kato Y; Horikoshi I; Nagase S; Ueda CT
Biopharm Drug Dispos; 1989; 10(3):299-309. PubMed ID: 2720133
[TBL] [Abstract][Full Text] [Related]
2. Disposition of salicylic acid in analbuminemic rats.
Hirate J; Horikoshi I; Watanabe J; Ozeki S; Nagase S
J Pharmacobiodyn; 1984 Dec; 7(12):929-34. PubMed ID: 6533283
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic action and disposition of gliclazide in normal and analbuminemic rats.
Imamura Y; Kimachi K; Nagase S; Otagiri M
Arch Int Pharmacodyn Ther; 1990; 304():44-54. PubMed ID: 2241418
[TBL] [Abstract][Full Text] [Related]
4. Transhepatic transport of taurocholic acid in normal and mutant analbuminemic rats.
Inoue M; Morino Y; Nagase S
Biochim Biophys Acta; 1985 Feb; 833(2):211-6. PubMed ID: 3970952
[TBL] [Abstract][Full Text] [Related]
5. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
[TBL] [Abstract][Full Text] [Related]
6. Drug protein binding and the nephrotic syndrome.
Gugler R; Azarnoff DL
Clin Pharmacokinet; 1976; 1(1):25-35. PubMed ID: 797490
[TBL] [Abstract][Full Text] [Related]
7. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.
Perucca E
Ther Drug Monit; 1980; 2(4):331-44. PubMed ID: 7013166
[TBL] [Abstract][Full Text] [Related]
8. Erythrocytes and the transport of drugs and endogenous compounds.
Highley MS; De Bruijn EA
Pharm Res; 1996 Feb; 13(2):186-95. PubMed ID: 8932435
[TBL] [Abstract][Full Text] [Related]
9. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
Fischer JH; Patel TV; Fischer PA
Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic reversion in analbuminemic rats due to an altered splicing mechanism.
Esumi H; Sugimura T
Proc Jpn Acad Ser B Phys Biol Sci; 2007 May; 83(4):101-9. PubMed ID: 24019588
[TBL] [Abstract][Full Text] [Related]
11. Disposition of phenytoin in analbuminemic rats.
Hirate J; Horikoshi I; Nagase S
Biopharm Drug Dispos; 1990 Dec; 11(9):773-83. PubMed ID: 2271753
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
